Navigation Links
NicOx Announces Departure of Damian Marron for CEO Position
Date:5/27/2008

SOPHIA ANTIPOLIS, France, May 27 /PRNewswire-FirstCall/ -- NicOx S.A. (Euronext Paris: COX) today announced that Damian Marron, Executive Vice President of Corporate Development, will be leaving the company on May 30th to become Chief Executive Officer of an early clinical stage biopharmaceutical company. Damian's responsibilities will be assumed by Sanjiv Sharma, Vice President Commercial Affairs and Gavin Spencer, Senior Director Business Development.

Michele Garufi, Chairman and CEO of NicOx, commented: "Since joining NicOx in 2002, Damian has made a great contribution to the growth and success of the Company, during which time we have advanced our lead compound naproxcinod into an extensive phase 3 clinical trial program and signed significant collaborative agreements with both Pfizer and Merck, amongst others. Damian has helped to establish a strong corporate development team, which will focus on the next phase of NicOx' development as a fully integrated biopharmaceutical company. We wish Damian every success in this exciting new opportunity with his new company."

Damian Marron said: "It has been a privilege to work at NicOx. During my six years, I have gained invaluable experience and have had the opportunity to broaden my skills such that I have now been offered this great opportunity to lead a biotechnology company. NicOx has established itself as one of Europe's leading biotechnology companies with a highly promising lead product and excellent relationships in the pharmaceutical industry. With a first rate management team in place to execute NicOx' strategy of becoming an integrated pharmaceutical company, I believe this is an excellent time to move on to the new challenge of the role of CEO."

NicOx (Bloomberg: COX:FP, Reuters: NCOX.PA) a product-driven biopharmaceutical company dedicated to the development and future commercialization of investigational drugs for unmet medical needs. NicOx is applying its proprietary nitric oxid
'/>"/>

SOURCE NicOx S.A.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. NicOx Signs Agreement for the Commercial Manufacture of Naproxcinod Drug Substance
2. NicOx Initiates Two Large ABPM Studies for Naproxcinod in Hypertensive Patients with Osteoarthritis
3. NicOx to Present at Financial Conferences in New York on November 27, 28 and 29
4. NicOx Opens U.S. Headquarters in New Jersey
5. CellCyte Genetics Corporation Announces Launch of Comprehensive Web site Powered by PRNewswire Investor Room Backend Technology
6. Favrille Announces Results from Phase 3 Registration Trial of Specifid in Patients with Follicular B-Cell Non-Hodgkins Lymphoma
7. Dragon Pharma Announces June 26, 2008 for 2008 Annual Shareholders Meeting
8. Cardium Therapeutics Announces Annual Meeting of Stockholders to be Held June 5, 2008
9. Oncolytics Biotech Inc. Announces Issuance of 9th Canadian Patent
10. Amnis Announces Release of Its Extended Depth of Field Option for The ImageStream(R) System
11. Amarin Announces Completion of the First Tranche of $60 Million Private Placement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... , July 29, 2015  AsureQuality and Ubiquitome ... testing for applications in food and primary production ... powered real-time PCR device, the Freedom4. ... through to the supermarket shelf for producers, processors ... involvement in animal disease control and pest management ...
(Date:7/29/2015)... , July 29, 2015 ... announced the addition of the "Global Biosimilars ... offering. The Global Biosimilars Market, 2015 ... the rapidly growing biosimilars market. With the blockbuster ... to minimize costs, biosimilars are being viewed as ...
(Date:7/29/2015)... CHICAGO , July 29, 2015  AmnioChor Inc., ... cell technology, is very pleased to announce that the ... has agreed to invest in their seed round ... OmniBank placental tissue storage capabilities. AmnioChor,s ... placenta, and the human stem cells living within those ...
(Date:7/29/2015)... 2015  Pfenex Inc. (NYSE MKT: PFNX) announced today ... released on Thursday, August 13, 2015, before the open ... will host a conference call to discuss the financial ... outlining the financial results and business update will be ... call 1-866-376-8058 (US) or 1-412-542-4131 (international) and reference Pfenex ...
Breaking Biology Technology:AsureQuality and Ubiquitome Partner on Applications for Mobile Molecular Food Safety Testing 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 3The Musculoskeletal Transplant Foundation Agrees to Invest in AmnioChor 2Pfenex To Report Second Quarter 2015 Results and Provide Business Update on Thursday, August 13, 2015 2
... Sigma-Aldrich (Nasdaq: SIAL ) announced today it has ... Your Favorite Gene powered by Ingenuity ( http://www.sigma-aldrich.com/yfg ... provides scientists access to dynamic gene-based content that they can ... of previously published scientific literature. , , "Your Favorite ...
... of Prophylaxis Therapy Label to Include Patient Labeling for Self-Administration ... ViroPharma Incorporated (Nasdaq: VPHM ) today announced that ... Food and Drug Administration (FDA) related to its supplemental Biologics ... a treatment for acute attacks of hereditary angioedema (HAE). ...
... Kornberg Associates | Architects ( www.kornberg.com ) ... the new Malaysia Genome Institute. Ken Kornberg, president and ... The Malaysia Genome Institute (GENOMalaysia; http://genome.ukm.my/ ) is ... government in April 2005. The institute, located in ...
Cached Biology Technology:Sigma-Aldrich Honored With CIO 100 Award for Innovative Web Research Tool, Your Favorite Gene powered by Ingenuity 2Sigma-Aldrich Honored With CIO 100 Award for Innovative Web Research Tool, Your Favorite Gene powered by Ingenuity 3ViroPharma Receives Complete Response Letter for Cinryze(TM) Supplemental Biologics License Application for Acute Treatment of Hereditary Angioedema 2ViroPharma Receives Complete Response Letter for Cinryze(TM) Supplemental Biologics License Application for Acute Treatment of Hereditary Angioedema 3ViroPharma Receives Complete Response Letter for Cinryze(TM) Supplemental Biologics License Application for Acute Treatment of Hereditary Angioedema 4ViroPharma Receives Complete Response Letter for Cinryze(TM) Supplemental Biologics License Application for Acute Treatment of Hereditary Angioedema 5Kornberg Associates Architects Selected to Design Research Areas of Malaysia Genome Institute 2
(Date:6/30/2015)... HATFIELD, Pa. , June 30, 2015 ... joined the company as CEO to help further develop ... a wealth of partnering experience, having spent much of ... companies including Therakine, Amgen, Baxter Bioscience, and Johnson & ... a focus on Technology and Biotech Corporate Finance. He ...
(Date:6/25/2015)... , June 25, 2015  Imagine a tool ... toward a healthier, happier life. That,s exactly what USANA,s ... to do. The cutting-edge, portable health program provides a ... solutions to help improve your lifestyle and nutrition. ... dinner and gala Wednesday night, USANA,s THA was honored ...
(Date:6/24/2015)... SAN JOSE, Calif. , June 24, 2015 ... leading developer of human interface solutions, today announced ... fingerprint sensor to provide secure authentication for its ... Having recently reached more than 200 million shipments ... shipment with Sharp reinforces Synaptics, strength, scalability and ...
Breaking Biology News(10 mins):Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2Synaptics Brings Natural ID Technology to Sharp's Newest Flagship Smartphone 2
... Queen Mary, University of London celebrates distinguished government scientist ... of the College this week. Chief Scientific Advisor ... (Defra) and notable Queen Mary alumnus, Professor Watson is ... science issues including ozone depletion and global warming. ...
... in Spanish . Agricultural Research ... an existing method for removing contaminants from storm water ... against runoff containing pollutants from point sources such as ... "Filter socks" containing compost tucked into mesh ...
... University of British Columbia zoologist has discovered a new ... and one of the earliest vertebrates dating back 500 ... evolution of steroid hormones and may help conservation and ... significant scientific implications and application for lamprey conservation," says ...
Cached Biology News:Honorary Fellowship awarded to government Chief Scientific Advisor 2'Super socks' help stem pollution runoff 2UBC researcher discovers ancient 'stress hormone' in pre-historic fish 2
Human HVEM/TNFRSF14 Allophycocyanin MAb (Clone 94801)...
LAL Chromogenic Endpoint assay...
RayBio Human Atherosclerosis Antibody Array 1.1 (4) with Accessory, detects 40 inflammatory factors (for lysate) Class: Antibody Array Products Product Group: Antibody Array...
Request Info...
Biology Products: